Ingelheim am Rhein, Germany

Michel Mikhail

This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Ingelheim Gmbh. Active years: 1997.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 43(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michel Mikhail: Innovator in Biodegradable Systems

Introduction

Michel Mikhail is a notable inventor based in Ingelheim am Rhein, Germany. He has made significant contributions to the field of biodegradable systems, particularly in the area of drug delivery. His innovative approach has the potential to enhance medical treatments while minimizing environmental impact.

Latest Patents

Michel Mikhail holds a patent for an "Implantable, biodegradable system for releasing active substance." This invention relates to a system designed to release active substances in a controlled manner, which can be crucial for various medical applications. His work in this area demonstrates a commitment to advancing healthcare technology.

Career Highlights

Michel Mikhail is associated with Boehringer Ingelheim GmbH, a leading global pharmaceutical company. His role at the company allows him to collaborate with other experts in the field, contributing to groundbreaking research and development. His patent portfolio includes 1 patent, showcasing his innovative capabilities.

Collaborations

Throughout his career, Michel has worked alongside esteemed colleagues such as Herbert Stricker and Gunther Entenmann. These collaborations have fostered an environment of creativity and innovation, leading to advancements in their respective fields.

Conclusion

Michel Mikhail is a prominent figure in the realm of biodegradable systems, with a focus on improving drug delivery methods. His contributions to the field are noteworthy, and his work continues to inspire future innovations in healthcare technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…